Astrazeneca Pharma India swung to a profit for the quarter ended March 2015. During the quarter, the company reported a profit of Rs 381.20 million compared with a loss of Rs 25.60 million in the same quarter previous year.
Revenues for the quarter jumped 47.66% to Rs 1,685.50 million, compared with Rs 1,142 million for the prior year period.
Earnings per share stood at Rs 15.25 compared with negative Rs 1.03 in the same quarter last year.
| Quarterly Results - Standalone (Rs in mn) |
| As at | Mar - 15 | Mar - 14 | %Change |
| Revenues | 1,685.50 | 1,141.50 | 47.66 |
| Net Profit | 381.20 | (25.60) | - |
| Diluted EPS | 15.25 | (1.03) | - |
Shares of the company gained Rs 104.15, or 12.14%, to trade at Rs 962.20. The total volume of shares traded was 46,869 at the BSE (1.21 p.m., Thursday).
